Ischemic heart disease in women: A focus on risk factors

Trends in Cardiovascular Medicine

Volumn 25, Issue 2, 2015, Pages 140-151

  Mehta, Puja K ^a   Wei, Janet ^a   Wenger, Nanette K ^b  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT; HORMONE;

ADVERSE OUTCOME; ANXIETY; AUTOIMMUNE DISEASE; CARDIOVASCULAR MORTALITY; DEPRESSION; DIABETES MELLITUS; DIETARY INTAKE; FEMALE BY MARITAL STATUS; FRAMINGHAM RISK SCORE; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MENTAL STRESS; MORBIDITY; PREGNANCY OUTCOME; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEDENTARY LIFESTYLE; SLEEP DISORDERED BREATHING; SMOKING; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SYSTEMIC DISEASE; UNITED STATES; WOMEN'S HEALTH; FEMALE; LIFESTYLE; MYOCARDIAL ISCHEMIA; PSYCHOLOGY; TRENDS;

FEMALE; HORMONES; HUMANS; LIFE STYLE; MYOCARDIAL ISCHEMIA; RISK FACTORS; WOMEN'S HEALTH;

EID: 84923047365     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2014.10.005     Document Type: Review

References (154)

1. Mosca L., Benjamin E.J., Berra K., Bezanson J.L., Dolor R.J., Lloyd-Jones D.M., et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011, 123:1243-1262.
2. Mulle J.G., Vaccarino V. Cardiovascular disease, psychosocial factors, and genetics: the case of depression. Prog Cardiovasc Dis 2013, 55:557-562.
3. Vaccarino V., Johnson B.D., Sheps D.S., Reis S.E., Kelsey S.F., Bittner V., et al. Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. J Am Coll Cardiol 2007, 50:2044-2050.
4. Pasternak R.C., Abrams J., Greenland P., Smaha L.A., Wilson P.W., Houston-Miller N. 34th Bethesda conference: task force #1-identification of coronary heart disease risk: is there a detection gap?. J Am Coll Cardiol 2003, 41:1863-1874.
5. Goff D.C., Lloyd-Jones D.M., Bennett G., Coady S., D'Agostino R.B., Gibbons R., et al. 2013 ACC/AHA Guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task force on practice guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2935-2959.
6. Messerli F.H., Williams B., Ritz E. Essential hypertension. Lancet 2007, 370:591-603.
7. Daugherty S.L., Masoudi F.A., Ellis J.L., Ho P.M., Schmittdiel J.A., Tavel H.M., et al. Age-dependent gender differences in hypertension management. J Hypertens 2011, 29:1005-1011.
8. Palatini P., Mos L., Santonastaso M., Saladini F., Benetti E., Mormino P., et al. Premenopausal women have increased risk of hypertensive target organ damage compared with men of similar age. J Womens Health 2011, 20:1175-1181.
9. Maas A.H., Franke H.R. Women's health in menopause with a focus on hypertension. Neth Heart J 2009, 17:68-72.
10. Gu Q., Burt V.L., Paulose-Ram R., Dillon C.F. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among us adults with hypertension: data from the National Health and Nutrition Examination survey 1999-2004. Am J Hypertens 2008, 21:789-798.
11. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. Heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 2013, 127:e6-e245.
12. Sorlie P.D., Allison M.A., Aviles-Santa M.L., Cai J., Daviglus M.L., Howard A.G., et al. Prevalence of hypertension, awareness, treatment, and control in the hispanic community health study/study of latinos. Am J Hypertens 2014, 27:793-800.
13. de la Sierra A., Segura J., Banegas J.R., Gorostidi M., de la Cruz J.J., Armario P., et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011, 57:898-902.
14. Stergiou G.S., Asayama K., Thijs L., Kollias A., Niiranen T.J., Hozawa A., et al. Prognosis of white-coat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome. Hypertension 2014, 63:675-682.
15. Krakoff L.R., Gillespie R.L., Ferdinand K.C., Fergus K.C., Akinboboye O., Williams K.A., et al. 2014 Hypertension recommendations from the eighth joint national committee panel members raise concerns for elderly black and female populations. J Am Coll Cardiol 2014, 64:394-402.
16. Yusuf S., Hawken S., Ounpuu S., Dans T., Avezum A., Lanas F., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004, 364:937-952.
17. Stone N.J., Robinson J., Lichtenstein A.H., Merz C.N., Blum C.B., Eckel R.H., et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation 2014, 129(25 Suppl 2):S1-45.
18. Kostis W.J., Cheng J.Q., Dobrzynski J.M., Cabrera J., Kostis J.B. Meta-analysis of statin effects in women versus men. J Am Coll Cardiol 2012, 59:572-582.
19. Bhattacharjee S., Findley P.A., Sambamoorthi U. Understanding gender differences in statin use among elderly medicare beneficiaries: an application of decomposition technique. Drugs Aging 2012, 29:971-980.
20. Bhardwaj S., Selvarajah S., Schneider E.B. Muscular effects of statins in the elderly female: a review. Clin Interv Aging 2013, 8:47-59.
21. Lu W., Resnick H.E., Jablonski K.A., Jones K.L., Jain A.K., Howard W.J., et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the Strong Heart Study. Diabetes Care 2003, 26:16-23.
22. Shai I., Rimm E.B., Hankinson S.E., Curhan G., Manson J.E., Rifai N., et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines. Circulation 2004, 110:2824-2830.
23. Njolstad I., Arnesen E., Lund-Larsen P.G. Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of The Finnmark Study. Circulation 1996, 93:450-456.
24. Teo K.K., Ounpuu S., Hawken S., Pandey M.R., Valentin V., Hunt D., et al. Tobacco use and risk of myocardial infarction in 52 countries in the interheart study: a case-control study. Lancet 2006, 368:647-658.
25. Huxley R.R., Woodward M. Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet 2011, 378:1297-1305.
26. Smith S.C., Benjamin E.J., Bonow R.O., Braun L.T., Creager M.A., Franklin B.A., et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and The Preventive Cardiovascular Nurses Association. J Am Coll Cardiol 2011, 58:2432-2446.
27. Huxley R., Barzi F., Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. Br Med J 2006, 332:73-78.
28. Gregg E.W., Gu Q., Cheng Y.J., Narayan K.M., Cowie C.C. Mortality trends in men and women with diabetes, 1971 to 2000. Ann Intern Med 2007, 147:149-155.
29. Kalyani R.R., Lazo M., Ouyang P., Turkbey E., Chevalier K., Brancati F., et al. Sex differences in diabetes and risk of incident coronary artery disease in healthy young and middle-aged adults. Diabetes Care 2014, 37:830-838.
30. Wannamethee S.G., Papacosta O., Lawlor D.A., Whincup P.H., Lowe G.D., Ebrahim S., et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia 2012, 55:80-87.
31. Golden S.H., Brown A., Cauley J.A., Chin M.H., Gary-Webb T.L., Kim C., et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an endocrine society scientific statement. J Clin Endocrinol Metab 2012, 97:E1579-E1639.
32. Mannucci E., Dicembrini I., Lauria A., Pozzilli P. Is glucose control important for prevention of cardiovascular disease in diabetes?. Diabetes Care 2013, 36(Suppl. 2):S259-S263.
33. Grenon S.M., Cohen B.E., Smolderen K., Vittinghoff E., Whooley M.A., Hiramoto J. Peripheral arterial disease, gender, and depression in The Heart and Soul study. J Vasc Surgery 2014, 60:396-403.
34. Jackson E.A., Munir K., Schreiber T., Rubin J.R., Cuff R., Gallagher K.A., et al. Impact of gender on morbidity and mortality rates following lower extremity interventions for peripheral arterial disease: observations from The Blue Cross Blue Shield of Michigan Cardiovascular Consortium. J Am Coll Cardiol 2014, 63:2525-2530.
35. Tullos B.W., Sung J.H., Lee J.E., Criqui M.H., Mitchell M.E., Taylor H.A. Ankle-brachial index (ABI), abdominal aortic calcification (AAC), and coronary artery calcification (CAC): the Jackson Heart study. Int J Cardiovas Imaging 2013, 29:891-897.
36. Sarnak M.J., Levey A.S., Schoolwerth A.C., Coresh J., Culleton B., Hamm L.L., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Hypertension 2003, 42:1050-1065.
37. Budoff M.J., Rader D.J., Reilly M.P., Mohler E.R., Lash J., Yang W., et al. Relationship of estimated GFR and coronary artery calcification in the CRIC (Chronic Renal Insufficiency Cohort) study. Am J Kidney Dis 2011, 58:519-526.
38. Reis S.E., Olson M.B., Fried L., Reeser V., Mankad S., Pepine C.J., et al. Mild renal insufficiency is associated with angiographic coronary artery disease in women. Circulation 2002, 105:2826-2829.
39. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004, 351:1296-1305.
40. Fuente-Martin E., Argente-Arizon P., Ros P., Argente J., Chowen J.A. Sex differences in adipose tissue: it is not only a question of quantity and distribution. Adipocyte 2013, 2:128-134.
41. Mahabadi A.A., Massaro J.M., Rosito G.A., Levy D., Murabito J.M., Wolf P.A., et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J 2009, 30:850-856.
42. Felix-Redondo F.J., Grau M., Baena-Diez J.M., Degano I.R., de Leon A.C., Guembe M.J., et al. Prevalence of obesity and associated cardiovascular risk: the DARIOS study. BMC Public Health 2013, 13:542.
43. Jensen M.D., Ryan D.H., Apovian C.M., Ard J.D., Comuzzie A.G., Donato K.A., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task force on Practice Guidelines and The Oobesity Society. Circulation 2014, 129(25 Suppl 2):S139-S140.
44. Jensen M.D., Ryan D.H., Apovian C.M., Ard J.D., Comuzzie A.G., Donato K.A., et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol 2014, 63:2985-3023.
45. O'Donnell C.J. Family history, subclinical atherosclerosis, and coronary heart disease risk: barriers and opportunities for the use of family history information in risk prediction and prevention. Circulation 2004, 110:2074-2076.
46. Paixao A.R., Berry J.D., Neeland I.J., Ayers C.R., Rohatgi A., de Lemos J.A., et al. Coronary artery calcification and family history of myocardial infarction in the dallas heart study. JACC Cadiovasc Imaging 2014, 7:679-686.
47. Kim C., Chang H.J., Cho I., Sung J.M., Choi D., Jeong M.H., et al. Impact of family history on the presentation and clinical outcomes of coronary heart disease: data from the korea acute myocardial infarction registry. Korean J Intern Med 2013, 28:547-556.
48. Sesso H.D., Lee I.M., Gaziano J.M., Rexrode K.M., Glynn R.J., Buring J.E. Maternal and paternal history of myocardial infarction and risk of cardiovascular disease in men and women. Circulation 2001, 104:393-398.
49. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in The Third National Health and Nutrition Examination Survey. Circulation 2004, 109:42-46.
50. Klein B.E., Klein R., Lee K.E. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. Diabetes Care 2002, 25:1790-1794.
51. Reilly M.P., Rader D.J. The metabolic syndrome: more than the sum of its parts?. Circulation 2003, 108:1546-1551.
52. Wu Z.J., Cheng Y.J., Gu W.J., Aung L.H. Adiponectin is associated with increased mortality in patients with already established cardiovascular disease: a systematic review and meta-analysis. Metabolism 2014, 63:1157-1166.
53. Lee S., Kwak H.B. Role of adiponectin in metabolic and cardiovascular disease. J Exerc Rehabil 2014, 10:54-59.
54. Christian R.C., Dumesic D.A., Behrenbeck T., Oberg A.L., Sheedy P.F., Fitzpatrick L.A. Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003, 88:2562-2568.
55. Wenger N.K. Recognizing pregnancy-associated cardiovascular risk factors. Am J Cardiol 2014, 113:406-409.
56. Ahmed R., Dunford J., Mehran R., Robson S., Kunadian V. Pre-eclampsia and future cardiovascular risk among women: a review. J Am Coll Cardiol 2014, 63:1815-1822.
57. Carr D.B., Newton K.M., Utzschneider K.M., Tong J., Gerchman F., Kahn S.E., et al. Preeclampsia and risk of developing subsequent diabetes. Hypertens Pregnancy 2009, 28:435-447.
58. Bushnell C., McCullough L.D., Awad I.A., Chireau M.V., Fedder W.N., Furie K.L., et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014, 45:1545-1588.
59. Roberts J.M., August P.A., Bakris G., Barton J.R., Bernstein I.M., Druzin M., et al. Hypertension in pregnancy. Report of The American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013, 122:1122-1131.
60. Gavin J.R., Alberti K., Davidson M.B., DeFronzo R.A., Drash A., Gabbe S.G., et al. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20.
61. Committee on Practice Bulletins-Obstetrics Practice bulletin no. 137: gestational diabetes mellitus. Obstet Gynecol 2013, 122:406-416.
62. VanDorsten J.P., Dodson W.C., Espeland M.A., Grobman W.A., Guise J.M., Mercer B.M., et al. National Institutes of Health consensus development conference statement: diagnosing gestational diabetes mellitus, March 4-6, 2013. Obstet Gynecol 2013, 122:358-369.
63. Zhang J., Chen L., Delzell E., Muntner P., Hillegass W.B., Safford M.M., et al. The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2014, 73:1301-1308.
64. Chung C.P., Giles J.T., Kronmal R.A., Post W.S., Gelber A.C., Petri M., et al. Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the multi-ethnic study of atherosclerosis. Arthritis Res Ther 2013, 15:R134.
65. Zeller C.B., Appenzeller S. Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors. Curr Cardiol Rev 2008, 4:116-122.
66. Chung C.P., Oeser A., Avalos I., Raggi P., Stein C.M. Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus 2006, 15:562-569.
67. Ishimori M.L., Martin R., Berman D.S., Goykhman P., Shaw L.J., Shufelt C., et al. Myocardial ischemia in the absence of obstructive coronary artery disease in systemic lupus erythematosus. J Am Coll Cardiol Cardiovasc Imaging 2011, 4:27-33.
68. Darby S.C., Ewertz M., McGale P., Bennet A.M., Blom-Goldman U., Bronnum D., et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013, 368:987-998.
69. Nilsson G., Holmberg L., Garmo H., Duvernoy O., Sjogren I., Lagerqvist B., et al. Distribution of coronary artery stenosis after radiation for breast cancer. J Clin Oncol 2012, 30:380-386.
70. Schultz-Hector S., Kallfass E., Sund M. Radiation sequelae in the large arteries. A review of clinical and experimental data. Strahlenther Onkol 1995, 171:427-436.
71. Somers V.K., White D.P., Amin R., Abraham W.T., Costa F., Culebras A., et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation scientific statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008, 118:1080-1111.
72. Shepertycky M.R., Banno K., Kryger M.H. Differences between men and women in the clinical presentation of patients diagnosed with obstructive sleep apnea syndrome. Sleep 2005, 28:309-314.
73. Quintana-Gallego E., Carmona-Bernal C., Capote F., Sanchez-Armengol A., Botebol-Benhamou G., Polo-Padillo J., et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir Med 2004, 98:984-989.
74. Tanko L.B., Christiansen C., Cox D.A., Geiger M.J., McNabb M.A., Cummings S.R. Relationship between osteoporosis and cardiovascular disease in postmenopausal women. J Bone Miner Res 2005, 20:1912-1920.
75. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
76. Melamed M.L., Michos E.D., Post W., Astor B. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008, 168:1629-1637.
77. Fortmann S.P., Burda B.U., Senger C.A., Lin J.S., Whitlock E.P. Vitamin and mineral supplements in the primary prevention of cardiovascular disease and cancer: an updated systematic evidence review for the U.S. Preventive services task force. Ann Intern Med 2013, 159:824-834.
78. Gunta S.S., Thadhani R.I., Mak R.H. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev. Nephrol 2013, 9:337-347.
79. Pilz S., Gaksch M., O'Hartaigh B., Tomaschitz A., Marz W. The role of vitamin D deficiency in cardiovascular disease: where do we stand in 2013?. Arch Toxicol 2013, 87:2083-2103.
80. Sarnak M.J., Tighiouart H., Manjunath G., MacLeod B., Griffith J., Salem D., et al. Anemia as a risk factor for cardiovascular disease in the atherosclerosis risk in communities Gara(ARIC) study. J Am Coll Cardiol 2002, 40:27-33.
81. Arant C.B., Wessel T.R., Olson M.B., Bairey Merz C.N., Sopko G., Rogers W.J., et al. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation study. J Am Coll Cardiol 2004, 43:2009-2014.
82. Mascitelli L., Goldstein M.R., Pezzetta F. Explaining sex difference in coronary heart disease: is it time to shift from the oestrogen hypothesis to the iron hypothesis?. J Cardiovasc Med 2011, 12:64-65.
83. Sullivan J.L. Iron and the sex difference in heart disease risk. Lancet 1981, 1:1293-1294.
84. Ridker P.M., Buring J.E., Rifai N., Cook N.R. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score. J Am Med Assoc 2007, 297:611-619.
85. Ridker P.M., Danielson E., Fonseca F.A., Genest J., Gotto A.M., Kastelein J.J., et al. Rosuvastatin to prevent vascular events in men and women with elevated c-reactive protein. N Engl J Med 2008, 359:2195-2207.
86. Doran B., Zhu W., Muennig P. Gender differences in cardiovascular mortality by C-reactive protein level in the United States: evidence from the National Health and Nutrition Examination Survey III. Am Heart J 2013, 166:45-51.
87. Kaptoge S., Di Angelantonio E., Pennells L., Wood A.M., White I.R., et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med 2012, 367:1310-1320. Emerging Risk Factors Collaboration.
88. Costanzo S., Di Castelnuovo A., Donati M.B., Iacoviello L., de Gaetano G. Cardiovascular and overall mortality risk in relation to alcohol consumption in patients with cardiovascular disease. Circulation 2010, 121:1951-1959.
89. Solomon C.G., Hu F.B., Stampfer M.J., Colditz G.A., Speizer F.E., Rimm E.B., et al. Moderate alcohol consumption and risk of coronary heart disease among women with type 2 diabetes mellitus. Circulation 2000, 102:494-499.
90. Brown W.J., Pavey T., Bauman A.E. Comparing population attributable risks for heart disease across the adult lifespan in women. Br J Sports Med 2014, 10.1136/bjsports-2013-093090.
91. Wienbergen H., Hambrecht R. Physical exercise and its effects on coronary artery disease. Curr Opin Pharmacol 2013, 13:218-225.
92. Wenger N.K. Current status of cardiac rehabilitation. J Am Coll Cardiol 2008, 51:1619-1631.
93. Ades P.A., Grunvald M.H. Cardiopulmonary exercise testing before and after conditioning in older coronary patients. Am Heart J 1990, 120:585-589.
94. Williams M.A., Ades P.A., Hamm L.F., Keteyian S.J., LaFontaine T.P., Roitman J.L., et al. Clinical evidence for a health benefit from cardiac rehabilitation: an update. Am Heart J 2006, 152:835-841.
95. Sanderson B.K., Shewchuk R.M., Bittner V. Cardiac rehabilitation and women: what keeps them away?. J Cardiopulm Rehabil Prev 2010, 30:12-21.
96. Anjo D., Santos M., Rodrigues P., Brochado B., Sousa M.J., Barreira A., et al. The benefits of cardiac rehabilitation in coronary heart disease: a gender issue?. Rev Port Cardiol 2014, 33:79-87.
97. Goel K., Lennon R.J., Tilbury R.T., Squires R.W., Thomas R.J. Impact of cardiac rehabilitation on mortality and cardiovascular events after percutaneous coronary intervention in the community. Circulation 2011, 123:2344-2352.
98. Fihn S.D., Gardin J.M., Abrams J., Berra K., Blankenship J.C., Dallas A.P., et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2012, 126:e354-e471.
99. Jneid H., Anderson J.L., Wright R.S., Adams C.D., Bridges C.R., Casey D.E., et al. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2012, 126:875-910.
100. O'Gara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., de Lemos J.A., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013, 127:e362-e425.
101. Levine G.N., Bates E.R., Blankenship J.C., Bailey S.R., Bittl J.A., Cercek B., et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and The Society for Cardiovascular angiography and interventions. Circulation 2011, 124:e574-e651.
102. Hillis L.D., Smith P.K., Anderson J.L., Bittl J.A., Bridges C.R., Byrne J.G., et al. 2011 ACCF/AHA guideline for coronary artery bypass graft surgery: a report of The American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011, 124:e652-e735.
103. Nishimura R.A., Otto C.M., Bonow R.O., Carabello B.A., Erwin J.P., Guyton R.A., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014, 129:e521-e643.
104. Yancy C.W., Jessup M., Bozkurt B., Butler J., Casey D.E., Drazner M.H., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation 2013, 128:e240-e327.
105. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:e391-e479.
106. Witt B.J., Jacobsen S.J., Weston S.A., Killian J.M., Meverden R.A., Allison T.G., et al. Cardiac rehabilitation after myocardial infarction in the community. J Am Coll Cardiol 2004, 44:988-996.
107. Suaya J.A., Shepard D.S., Normand S.L., Ades P.A., Prottas J., Stason W.B. Use of cardiac rehabilitation by medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 2007, 116:1653-1662.
108. Arena R., Williams M., Forman D.E., Cahalin L.P., Coke L., Myers J., et al. Increasing referral and participation rates to outpatient cardiac rehabilitation: the valuable role of healthcare professionals in the inpatient and home health settings: a science advisory from the American Heart Association. Circulation 2012, 125:1321-1329.
109. Estruch R., Ros E., Martinez-Gonzalez M.A. Mediterranean diet for primary prevention of cardiovascular disease. N Engl J Med 2013, 369:676-677.
110. Howard B.V., Van Horn L., Hsia J., Manson J.E., Stefanick M.L., Wassertheil-Smoller S., et al. Low-fat dietary pattern and risk of cardiovascular disease: the women's health initiative randomized controlled dietary modification trial. J Am Med Assoc 2006, 295:655-666.
111. Chiuve S.E., Rimm E.B., Manson J.E., Whang W., Mozaffarian D., Stampfer M.J., et al. Intake of total trans, trans-18:1, and trans-18:2 fatty acids and risk of sudden cardiac death in women. Am Heart J 2009, 158:761-767.
112. Kiage J.N., Merrill P.D., Robinson C.J., Cao Y., Malik T.A., Hundley B.C., et al. Intake of trans fat and all-cause mortality in the reasons for geographical and racial differences in stroke (regards) cohort. Am J Clin Nutr 2013, 97:1121-1128.
113. Bertoia M.L., Triche E.W., Michaud D.S., Baylin A., Hogan J.W., Neuhouser M.L., et al. Mediterranean and dietary approaches to stop hypertension dietary patterns and risk of sudden cardiac death in postmenopausal women. Am J Clin Nutr 2014, 99:344-351.
114. Koeth R.A., Wang Z., Levison B.S., Buffa J.A., Org E., Sheehy B.T., et al. Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 2013, 19:576-585.
115. Tang W.H., Wang Z., Levison B.S., Koeth R.A., Britt E.B., Fu X., et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med 2013, 368:1575-1584.
116. Prasad A., Lerman A., Rihal C.S. Apical ballooning syndrome (tako-tsubo or stress cardiomyopathy): a mimic of acute myocardial infarction. Am Heart J 2008, 155:408-417.
117. Kohan A.A., Levy Yeyati E., De Stefano L., Dragonetti L., Pietrani M., Perez de Arenaza D., et al. Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature. Cardiovasc Diagn Ther 2014, 4:138-146.
118. Pelliccia F., Greco C., Vitale C., Rosano G., Gaudio C., Kaski J.C. Takotsubo syndrome (stress cardiomyopathy): an intriguing clinical condition in search of its identity. Am J Med 2014, 127:699-704.
119. Summers M.R., Prasad A. Takotsubo cardiomyopathy: definition and clinical profile. Heart Fail Clin 2013, 9:111-122. (vii).
120. Sharkey S.W., Windenburg D.C., Lesser J.R., Maron M.S., Hauser R.G., Lesser J.N., et al. Natural history and expansive clinical profile of stress (tako-tsubo) cardiomyopathy. J Am Coll Cardiol 2010, 55:333-341.
121. Patel S.M., Lerman A., Lennon R.J., Prasad A. Impaired coronary microvascular reactivity in women with apical ballooning syndrome (takotsubo/stress cardiomyopathy). Eur Heart J Acute Cardiovasc Care 2013, 2:147-152.
122. Agrawal M., Shufelt C., Mehta P.K., Ed Gill, Berman D.S., Li D., et al. Cardiac risk factors and myocardial perfusion reserve in women with microvascular coronary dysfunction. Cardiovasc Diag Ther 2013, 3(3):146-152.
123. Vaccarino V., Shah A.J., Rooks C., Ibeanu I., Nye J.A., Pimple P., et al. Sex differences in mental stress-induced myocardial ischemia in young survivors of an acute myocardial infarction. Psychosom Med 2014, 76:171-180.
124. Lichtman J.H., Froelicher E.S., Blumenthal J.A., Carney R.M., Doering L.V., Frasure-Smith N., et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from The American Heart Association. Circulation 2014, 129:1350-1369.
125. Shah A.J., Ghasemzadeh N., Zaragoza-Macias E., Patel R., Eapen D.J., Neeland I.J., et al. Sex and age differences in the association of depression with obstructive coronary artery disease and adverse cardiovascular events. J Am Heart Assoc 2014, 3:e000741.
126. Wassertheil-Smoller S., Shumaker S., Ockene J., Talavera G.A., Greenland P., Cochrane B., et al. Depression and cardiovascular sequelae in postmenopausal women. The women's health initiative (WHI). Arch Intern Med 2004, 164:289-298.
127. Whang W., Kubzansky L.D., Kawachi I., Rexrode K.M., Kroenke C.H., Glynn R.J., et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from The Nurses' Health study. J Am Coll Cardiol 2009, 53:950-958.
128. de Groot M., Anderson R., Freedland K.E., Clouse R.E., Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001, 63:619-630.
129. Rutledge T., Linke S.E., Johnson B.D., Bittner V., Krantz D.S., Cornell C.E., et al. Relationships between cardiovascular disease risk factors and depressive symptoms as predictors of cardiovascular disease events in women. J Womens Health 2012, 21:133-139.
130. Berkman L.F., Blumenthal J., Burg M., Carney R.M., Catellier D., Cowan M.J., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. J Am Med Assoc 2003, 289:3106-3116.
131. Glassman A.H., Bigger J.T., Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of sadhart participants. Arch Gen Psychiatry 2009, 66:1022-1029.
132. Zuidersma M., Conradi H.J., van Melle J.P., Ormel J., de Jonge P. Depression treatment after myocardial infarction and long-term risk of subsequent cardiovascular events and mortality: a randomized controlled trial. J Psychosom Res 2013, 74:25-30.
133. Orth-Gomer K., Schneiderman N., Wang H.X., Walldin C., Blom M., Jernberg T. Stress reduction prolongs life in women with coronary disease: the stockholm women's intervention trial for coronary heart disease (SWITCHD). Circulation 2009, 2:25-32.
134. Lichtman J.H., Bigger J.T., Blumenthal J.A., Frasure-Smith N., Kaufmann P.G., Lesperance F., et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association prevention committee of the council on Cardiovascular Nursing, council on Clinical Cardiology, council on Epidemiology and Prevention, and Interdisciplinary council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.
135. Roest A.M., Martens E.J., Denollet J., de Jonge P. Prognostic association of anxiety post myocardial infarction with mortality and new cardiac events: a meta-analysis. Psychosom Med 2010, 72:563-569.
136. Roest A.M., Martens E.J., de Jonge P., Denollet J. Anxiety and risk of incident coronary heart disease: a meta-analysis. J Am Coll Cardiol 2010, 56:38-46.
137. Williams J.E., Paton C.C., Siegler I.C., Eigenbrodt M.L., Nieto F.J., Tyroler H.A. Anger proneness predicts coronary heart disease risk: prospective analysis from the atherosclerosis risk in communities (ARIC) study. Circulation 2000, 101:2034-2039.
138. Moller J., Hallqvist J., Diderichsen F., Theorell T., Reuterwall C., Ahlbom A. Do episodes of anger trigger myocardial infarction? A case-crossover analysis in the Stockholm Heart Epidemiology Program (SHEEP). Psychosom Med 1999, 61:842-849.
139. Mostofsky E., Penner E.A., Mittleman M.A. Outbursts of anger as a trigger of acute cardiovascular events: a systematic review and meta-analysisdagger. Eur Heart J 2014, 35:1404-1410.
140. Orth-Gomer K., Wamala S.P., Horsten M., Schenck-Gustafsson K., Schneiderman N., Mittleman M.A. Marital stress worsens prognosis in women with coronary heart disease: the stockholm female coronary risk study. J Am Med Assoc 2000, 284:3008-3014.
141. Lee J.R., Paultre F., Mosca L. The association between educational level and risk of cardiovascular disease fatality among women with cardiovascular disease. Womens Health Issues 2005, 15:80-88.
142. Albert M.A., Glynn R.J., Buring J., Ridker P.M. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006, 114:2619-2626.
143. Wamala S.P., Mittleman M.A., Horsten M., Schenck-Gustafsson K., Orth-Gomer K. Job stress and the occupational gradient in coronary heart disease risk in women. The stockholm female coronary risk study. Soc Sci Med 2000, 51:481-489.
144. WHO Ischaemic stroke and combined oral contraceptives: results of an international, multicentre, case-control study. WHO collaborative study of cardiovascular disease and steroid hormone contraception. Lancet 1996, 348:498-505.
145. Lubianca J.N., Faccin C.S., Fuchs F.D. Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women. Contraception 2003, 67:19-24.
146. Shufelt C.L., Bairey Merz C.N. Contraceptive hormone use and cardiovascular disease. J Am Coll Cardiol 2009, 53:221-231.
147. Tanis B.C., van den Bosch M.A., Kemmeren J.M., Cats V.M., Helmerhorst F.M., Algra A., et al. Oral contraceptives and the risk of myocardial infarction. N Engl J Med 2001, 345:1787-1793.
148. Rexrode K.M., Manson J.E., Lee I.M., Ridker P.M., Sluss P.M., Cook N.R., et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation 2003, 108:1688-1693.
149. Rossouw J.E., Anderson G.L., Prentice R.L., LaCroix A.Z., Kooperberg C., Stefanick M.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial. J Am Med Assoc 2002, 288:321-333.
150. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and estrogen/progestin replacement study (HERS) research group. J Am Med Assoc 1998, 280:605-613.
151. Manson J.E., Allison M.A., Rossouw J.E., Carr J.J., Langer R.D., Hsia J., et al. Estrogen therapy and coronary-artery calcification. N Engl J Med 2007, 356:2591-2602.
152. Wolff E.F., He Y., Black D.M., Brinton E.A., Budoff M.J., Cedars M.I., et al. Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS). Fertil Steril 2013, 99:1385-1391.
153. Brinton E., Nanjee N., Hopkins P.N., Santoro N., Neal-Perry G., Taylor H., et al. Oral estrogen vs. Transdermal estrogen effects on lipids and lipoproteins in recently menopausal women: the Kronos Early Estrogen Prevention Study (KEEPS). Menopause 2013, 19:1365-1404.
154. Painovich J.M., Shufelt C.L., Azziz R., Yang Y., Goodarzi M.O., Braunstein G.D., et al. A pilot randomized, single-blind, placebo-controlled trial of traditional acupuncture for vasomotor symptoms and mechanistic pathways of menopause. Menopause 2012, 19:54-61.